Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2011-06-06 Regulatory Filings
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings
2011-06-06 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter from SurModics, Inc. to the SEC responding to comments on their previously filed Form 10-K for the fiscal year ended September 30, 2010, and Form 10-Q for the quarter ended December 31, 2010. It discusses specific accounting and disclosure issues related to contingent consideration and milestone payments, referencing these filings and their preparation. The letter is a regulatory correspondence addressing SEC staff comments and does not contain the actual financial statements or full report content. It is primarily a regulatory filing responding to SEC inquiries rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS).
2011-05-26 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 24, 2011, for SurModics, Inc. It references an attached slide presentation (Exhibit 99.1) from an analyst meeting, containing historical results and non-GAAP financial measures. The text states that the information is furnished pursuant to Items 2.02 and 7.01 of Form 8-K, which relate to results of operations and financial condition updates. The document is primarily an announcement of a presentation and financial information shared at an analyst meeting, not a full financial report or earnings release. The document length is 3662 characters, which is relatively short and mainly serves to announce and furnish the presentation slides. Therefore, this filing is best classified as an Investor Presentation (IP).
2011-05-24 English
FORM 4 SUBMISSION
Director's Dealing
2011-05-23 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 16, 2011, for SurModics, Inc. The key content is under Item 5.02, which discusses the departure, election, or appointment of directors or certain officers, specifically the approval of severance benefits for a senior vice president. This matches the description of Board/Management Information filings, which announce changes or arrangements related to the company's board or senior management. The document is relatively short (3122 characters) and contains specific management-related information rather than financial results or other report types. Therefore, the appropriate classification is MANG (Board/Management Information).
2011-05-20 English
10-Q Filing
Interim / Quarterly Report Q2 2011
2011-05-10 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.